Leah Laboratories is pioneering the use of CAR-T cell therapy in veterinary medicine, specifically targeting cancer in dogs. This innovative approach involves engineering living immune cells to combat cancer, a method that has already shown curative potential in humans with blood cancers. Leah Labs has achieved a significant milestone by being the first organization to successfully induce remission in dogs using this therapy. Their work not only aims to revolutionize oncology for companion animals but also contributes valuable insights that could enhance CAR-T cell therapies for human patients in the future.

The company is actively engaged in developing therapies that address the pressing issue of cancer, which affects approximately 6 million dogs annually. By focusing on the intersection of veterinary and human medicine, Leah Laboratories is positioned to make a substantial impact on cancer treatment for both pets and their owners. Their research and development efforts are supported by a range of investors and grants, highlighting the growing interest and investment in innovative solutions for cancer treatment in both animals and humans.

United States

LEAH Laboratories is a biotechnology company that specializes in building living therapies for pets and their people.

Leah Laboratories

Company Details